Dr. Evan Levine tackles a drug that is often prescribed to help children perform better — a phenomenon he calls “borderline ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.

Bristol Myers Squibb BMY suffered a setback in the late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

The focus is on a drug called Lepodisiran, that could target certain factors that increase risk of heart attacks and strokes.

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, a new study ...

The differences in risk of sudden cardiac death varied by age and how long people took antidepressants, with people taking ...

Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of ...

ADHD medications raise heart rate and blood pressure meaning wider cardiovascular monitoring across all treatments is required.

The rise in the use of certain weight loss drugs is being credited not only for its potential to help people shed pounds, but ...